Research to Prevent Blindness Archives
Insights on diabetic retinopathy
Jan. 23, 2020—A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.
Potassium balance and glaucoma
Jul. 15, 2019—Vanderbilt Eye Institute researchers have discovered that an imbalance in the ionic environment of retinal ganglion cells may contribute to functional impairments in glaucoma.
Research to Prevent Blindness awards grants to Department of Ophthalmology
Jul. 1, 2019—Vanderbilt Eye Institute receives grants to Research to study causes, treatment and prevention of blinding diseases.
Novel methods to treat glaucoma
Nov. 8, 2018—Increasing a certain signaling molecule prevents the degeneration of retinal cells that are lost in glaucoma, suggesting a new way to treat this disease.
Calkins lands innovation award from Research to Prevent Blindness
Jun. 28, 2018—Jun. 28, 2018—David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has been granted one of the preeminent awards in vision research — the Research to Prevent Blindness (RPB) Stein Innovation Award.
Two receive Research to Prevent Blindness grants
Jul. 21, 2016—Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology.
VEI receives grant from Research to Prevent Blindness for research and education
Jun. 25, 2015—The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.
Retinal neuron survival in glaucoma
Dec. 16, 2014—Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.
Biomarker for diabetic eye disease
Sep. 26, 2014—A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.
Keeping an eye on blast trauma
Aug. 19, 2014—Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.
Protein boosts retinal neuron survival
Mar. 14, 2014—An ion channel protein called TRIPV1 helps retinal neurons survive the elevated eye pressure associated with glaucoma.
Penn named to vision group’s scientific advisory panel
Oct. 31, 2013—John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, has been named to the Research to Prevent Blindness (RPB) Scientific Advisory Panel.
